The First SHAPE (Screening for Heart Attack Prevention and Education) guideline

Critical Pathways in Cardiology

Volumn 5, Issue 4, 2006, Pages 187-190

  Naghavi, Morteza ^a   Falk, Erling ^b   Hecht, Harvey S ^c   Shah, Prediman K ^d  

^a Association for Eradication of Heart Attack   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LENOX HILL HOSPITAL   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Carotid intima media thickness; Coronary calcium score; Primary prevention; Screening; Vulnerable patient; Vulnerable plaque

Indexed keywords

ARTERY INTIMA PROLIFERATION; B SCAN; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MEDICAL EDUCATION; NON INVASIVE PROCEDURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SOCIAL ASPECT; STROKE;

EID: 33845496765     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000249784.29151.54     Document Type: Review

References (11)

1. Naghavi M, Falk E, Hecht HS, et al; SHAPE Task Force. From vulnerable plaque to vulnerable patient - Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H-15H.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
3. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
4. Smith SC Jr, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. Circulation. 2000;101:111-116.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al, for the Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Available at: www.escardio.org/NR/rdonlyres/A0EF5CA5-421B- 45EF-A65C-19B9EC411261/0/CVD_Prevention_03_full.pdf. Accessed June 11, 2006.
6. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation. 2003;108:1664-1672.
7. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation. 2003;108:1772-1778.
8. Akosah K, Schaper A, Cogbil C, et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475-1479.
9. Kalia NK, Miller LG, Nasir K, et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399.
10. Shah PK, Chyu KY, Fredrikson GN, et al. Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med. 2005;2:639-646.
11. Naghavi M. The mission of the Association for Eradication of Heart Attack [Association for Eradication of Heart Attack web site]. Available at: www.aeha.org/mission.html. Accessed June 11, 2006.